Targeted therapy is changing how doctors treat liver cancer, especially in advanced stages where surgery isn’t possible. By blocking the specific growth signals that fuel tumors, these treatments slow cancer progression, cut off blood supply to tumors, and support the immune system, all with fewer side effects than chemotherapy. In this episode, you’ll learn: How targeted therapy works to block tumor growth signals The difference between tyrosine kinase inhibitors (TKIs) and monoclonal antibodies Who benefits most from targeted therapy for liver cancer Why does this approach often cause fewer side effects than chemotherapy How targeted therapy helps after other treatments stop working The role of clinical trials in developing new targeted therapies Why combining targeted drugs with immunotherapy improves long-term outcomes This episode offers a clear look at how targeted therapy is transforming liver cancer treatment, giving patients more options and better control over their disease. Blog Link: Targeted Therapy for Liver Cancer Send us a text Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education. Author: Dr. CHRISTINA NG VAN TZE 📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
